Dissociation of vasomotor and metabolic responses to levodopa has been observed in human subjects with Parkinson's disease (PD) studied with PET and in autoradiograms from 6-hydroxydopamine (6-OHDA) rat. In both species, acute levodopa administration was associated with increases in basal ganglia cerebral blood flow (CBF) with concurrent reductions in cerebral metabolic rate (CMR) for glucose in the same brain regions. In this study, we used a novel dual-tracer microPET technique to measure CBF and CMR levodopa responses in the same animal. Rats with unilateral 6-OHDA or sham lesion underwent sequential 15O-water (H2 15O) and 18F-fluorodeoxyglucose (FDG) microPET to map CBF and CMR following the injection of levodopa or saline. A subset of ...
Levodopa-induced dyskinesias (LIDs) occur in the majority of patients with Parkinson's disease (PD) ...
It is important to elucidate the mechanism of dysautonomias in patients with Parkinson's disease; th...
Chronic use of levodopa, the most effective treatment for Parkinson's disease, causes abnormal invol...
Dissociation of vasomotor and metabolic responses to levodopa has been observed in human subjects wi...
Chronic levodopa treatment leads to the appearance of dyskinesia in the majority of Parkinson's dise...
Preclinical imaging of brain activity requires the use of anesthesia. In this study, we have compare...
Evaluate the effects caused by L-DOPA on cardiovascular and autonomic parameters in an animal model ...
Introduction. Levodopa is the gold-standard for treatment of Parkinson’s disease (PD) related motor ...
Parkinson´s disease (PD) is characterized by nigro-striatal loss and dopaminergic striatal depletion...
The aim of this work was to study cerebral vasoreactivity to hypercapnia in Parkinson's disease (PD)...
Parkinson‘s disease (PD) is a progressive and disabling neurodegenerative disease, characterized by ...
The current pharmacotherapy of Parkinson's disease (PD) is primarily based on two classes of drugs: ...
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by a loss of dopamine...
International audienceThe aim of this work was to study cerebral vasoreactivity to hypercapnia in Pa...
Levodopa (l-dopa) has been at the forefront of antiparkinsonian therapy for a half century. Recent a...
Levodopa-induced dyskinesias (LIDs) occur in the majority of patients with Parkinson's disease (PD) ...
It is important to elucidate the mechanism of dysautonomias in patients with Parkinson's disease; th...
Chronic use of levodopa, the most effective treatment for Parkinson's disease, causes abnormal invol...
Dissociation of vasomotor and metabolic responses to levodopa has been observed in human subjects wi...
Chronic levodopa treatment leads to the appearance of dyskinesia in the majority of Parkinson's dise...
Preclinical imaging of brain activity requires the use of anesthesia. In this study, we have compare...
Evaluate the effects caused by L-DOPA on cardiovascular and autonomic parameters in an animal model ...
Introduction. Levodopa is the gold-standard for treatment of Parkinson’s disease (PD) related motor ...
Parkinson´s disease (PD) is characterized by nigro-striatal loss and dopaminergic striatal depletion...
The aim of this work was to study cerebral vasoreactivity to hypercapnia in Parkinson's disease (PD)...
Parkinson‘s disease (PD) is a progressive and disabling neurodegenerative disease, characterized by ...
The current pharmacotherapy of Parkinson's disease (PD) is primarily based on two classes of drugs: ...
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by a loss of dopamine...
International audienceThe aim of this work was to study cerebral vasoreactivity to hypercapnia in Pa...
Levodopa (l-dopa) has been at the forefront of antiparkinsonian therapy for a half century. Recent a...
Levodopa-induced dyskinesias (LIDs) occur in the majority of patients with Parkinson's disease (PD) ...
It is important to elucidate the mechanism of dysautonomias in patients with Parkinson's disease; th...
Chronic use of levodopa, the most effective treatment for Parkinson's disease, causes abnormal invol...